SNDA
Sonida Senior Living, Inc.
Medical - Care Facilities
Market Cap$695M
5Y Perf.+269.5%
Compare Stocks
5 / 10Try these comparisons:
Stock Comparison
SNDA vs UNH vs CVS vs HUM vs ELV
Revenue, margins, valuation, and 5-year total return — side by side.
UNH
UnitedHealth Group Incorporated
Medical - Healthcare Plans
Market Cap$335.60B
5Y Perf.+21.3%
CVS
CVS Health Corporation
Medical - Healthcare Plans
Market Cap$111.40B
5Y Perf.+33.2%
HUM
Humana Inc.
Medical - Healthcare Plans
Market Cap$29.67B
5Y Perf.-39.8%
ELV
Elevance Health Inc.
Medical - Healthcare Plans
Market Cap$80.98B
5Y Perf.+26.8%
SNDA vs UNH vs CVS vs HUM vs ELV — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | SNDA | UNH | CVS | HUM | ELV |
|---|---|---|---|---|---|
| Industry | Medical - Care Facilities | Medical - Healthcare Plans | Medical - Healthcare Plans | Medical - Healthcare Plans | Medical - Healthcare Plans |
| Market Cap | $695M | $335.60B | $111.40B | $29.67B | $80.98B |
| Revenue (TTM) | $381M | $449.71B | $407.90B | $137.20B | $200.41B |
| Net Income (TTM) | $-71M | $12.04B | $2.93B | $1.13B | $5.24B |
| Gross Margin | -8.0% | 18.8% | 13.9% | 14.0% | 23.2% |
| Operating Margin | -15.3% | 4.2% | 1.5% | 1.0% | 3.8% |
| Forward P/E | — | 20.2x | 12.2x | 27.7x | 13.9x |
| Total Debt | $690M | $78.39B | $93.59B | $12.94B | $33.23B |
| Cash & Equiv. | $11M | $24.36B | $8.51B | $4.20B | $9.49B |
SNDA vs UNH vs CVS vs HUM vs ELV — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
SNDA
UNH
CVS
HUM
ELV
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Sonida Senior Livin… (SNDA) | 100 | 369.5 | +269.5% |
| UnitedHealth Group … (UNH) | 100 | 121.3 | +21.3% |
| CVS Health Corporat… (CVS) | 100 | 133.2 | +33.2% |
| Humana Inc. (HUM) | 100 | 60.2 | -39.8% |
| Elevance Health Inc. (ELV) | 100 | 126.8 | +26.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SNDA vs UNH vs CVS vs HUM vs ELV
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: CVS leads in 3 of 7 categories (5-stock set), making it the strongest pick for valuation and capital efficiency and capital preservation and lower volatility. Sonida Senior Living, Inc. is the stronger pick specifically for growth and revenue expansion and recent price momentum and sentiment. UNH and ELV also each lead in at least one category. As sector peers, any of these can serve as alternatives in the same allocation.
SNDA
Sonida Senior Living, Inc.
The Growth Play
SNDA is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 25.2%, EPS growth -6.8%, 3Y rev CAGR 16.9%
- 25.2% revenue growth vs CVS's 7.8%
- +52.7% vs ELV's -9.0%
Best for: growth exposure
UNH
UnitedHealth Group Incorporated
The Insurance Pick
UNH ranks third and is worth considering specifically for long-term compounding.
- 220.6% 10Y total return vs ELV's 202.1%
- 2.7% margin vs SNDA's -18.7%
Best for: long-term compounding
CVS
CVS Health Corporation
The Insurance Pick
CVS carries the broadest edge in this set and is the clearest fit for income & stability and defensive.
- Dividend streak 0 yrs, beta 0.05, yield 3.1%
- Beta 0.05, yield 3.1%, current ratio 0.84x
- Lower P/E (12.2x vs 13.9x)
- Beta 0.05 vs SNDA's 1.10, lower leverage
Best for: income & stability and defensive
HUM
Humana Inc.
The Insurance Play
Among these 5 stocks, HUM doesn't own a clear edge in any measured category.
Best for: healthcare exposure
ELV
Elevance Health Inc.
The Insurance Pick
ELV is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 0.46, Low D/E 75.5%, current ratio 1.24x
- 4.3% ROA vs SNDA's -8.4%, ROIC 9.1% vs -5.8%
Best for: sleep-well-at-night
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | SNDA | 25.2% revenue growth vs CVS's 7.8% |
| Value | CVS | Lower P/E (12.2x vs 13.9x) |
| Quality / Margins | UNH | 2.7% margin vs SNDA's -18.7% |
| Stability / Safety | CVS | Beta 0.05 vs SNDA's 1.10, lower leverage |
| Dividends | CVS | 3.1% yield, vs UNH's 2.4% |
| Momentum (1Y) | SNDA | +52.7% vs ELV's -9.0% |
| Efficiency (ROA) | ELV | 4.3% ROA vs SNDA's -8.4%, ROIC 9.1% vs -5.8% |
SNDA vs UNH vs CVS vs HUM vs ELV — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2024
FY 2025
FY 2025
FY 2025
FY 2025
SNDA vs UNH vs CVS vs HUM vs ELV — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLCVSLAGGINGHUM
Who Leads Where
CVS leads in 2 of 6 categories
UNH leads 1 • ELV leads 1 • SNDA leads 1 • HUM leads 0 • 1 tied
Explore the data ↓HUMHumana Inc.
0leads
ELVElevance Health Inc.
1leads
UNHUnitedHealth Group In…
1leads
SNDASonida Senior Living,…
1leads
CVSCVS Health Corporation
2leads
6 Total Categories
CATEGORYLEADERvs SNDAvs UNHMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
UNH3/6
Valuation MetricsMultiples, price ratios, and targets
CVS3/6
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
ELV4/9
Total Returns1Y, 3Y, 5Y total returns with dividends
SNDA4/6
Risk & VolatilityBeta, volatility, and downside exposure
CVS2/2
Analyst OutlookRatings, price targets, and dividends
Tied
—
Income & Cash Flow (Last 12 Months)
UNH leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
UNH is the larger business by revenue, generating $449.7B annually — 1179.9x SNDA's $381M. UNH is the more profitable business, keeping 2.7% of every revenue dollar as net income compared to SNDA's -18.7%. On growth, HUM holds the edge at +23.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | SNDASonida Senior Liv… | UNHUnitedHealth Grou… | CVSCVS Health Corpor… | HUMHumana Inc. | ELVElevance Health I… |
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $381M | $449.7B | $407.9B | $137.2B | $200.4B |
| EBITDAEarnings before interest/tax | -$1M | $23.2B | $10.5B | $2.2B | $8.9B |
| Net IncomeAfter-tax profit | -$71M | $12.0B | $2.9B | $1.1B | $5.2B |
| Free Cash FlowCash after capex | -$9M | $19.7B | $7.4B | $1.3B | $6.5B |
| Gross MarginGross profit ÷ Revenue | -8.0% | +18.8% | +13.9% | +14.0% | +23.2% |
| Operating MarginEBIT ÷ Revenue | -15.3% | +4.2% | +1.5% | +1.0% | +3.8% |
| Net MarginNet income ÷ Revenue | -18.7% | +2.7% | +0.7% | +0.8% | +2.6% |
| FCF MarginFCF ÷ Revenue | -2.3% | +4.4% | +1.8% | +0.9% | +3.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +6.2% | +2.0% | +6.2% | +23.5% | +2.6% |
| EPS Growth (YoY)Latest quarter vs prior year | -3.5% | +0.7% | +63.1% | -4.6% | -16.8% |
UNH leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
CVS leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 14.8x trailing earnings, ELV trades at a 76% valuation discount to CVS's 62.8x P/E. On an enterprise value basis, ELV's 10.8x EV/EBITDA is more attractive than HUM's 16.9x.
| Metric | SNDASonida Senior Liv… | UNHUnitedHealth Grou… | CVSCVS Health Corpor… | HUMHumana Inc. | ELVElevance Health I… |
|---|---|---|---|---|---|
| Market CapShares × price | $695M | $335.6B | $111.4B | $29.7B | $81.0B |
| Enterprise ValueMkt cap + debt − cash | $1.4B | $389.6B | $196.5B | $38.4B | $104.7B |
| Trailing P/EPrice ÷ TTM EPS | -8.67x | 27.95x | 62.81x | 25.12x | 14.84x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 20.19x | 12.19x | 27.68x | 13.93x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | 2.15x |
| EV / EBITDAEnterprise value multiple | — | 16.70x | 13.11x | 16.87x | 10.84x |
| Price / SalesMarket cap ÷ Revenue | 1.82x | 0.75x | 0.28x | 0.23x | 0.41x |
| Price / BookPrice ÷ Book value/share | 11.76x | 3.31x | 1.47x | 1.68x | 1.88x |
| Price / FCFMarket cap ÷ FCF | — | 20.88x | 14.27x | 79.13x | 25.51x |
CVS leads this category, winning 3 of 6 comparable metrics.
Profitability & Efficiency
ELV leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
ELV delivers a 11.9% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-76 for SNDA. HUM carries lower financial leverage with a 0.73x debt-to-equity ratio, signaling a more conservative balance sheet compared to SNDA's 12.26x. On the Piotroski fundamental quality scale (0–9), UNH scores 6/9 vs SNDA's 3/9, reflecting solid financial health.
| Metric | SNDASonida Senior Liv… | UNHUnitedHealth Grou… | CVSCVS Health Corpor… | HUMHumana Inc. | ELVElevance Health I… |
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -76.4% | +11.5% | +3.9% | +6.2% | +11.9% |
| ROA (TTM)Return on assets | -8.4% | +3.9% | +1.1% | +2.2% | +4.3% |
| ROICReturn on invested capital | -5.8% | +9.2% | +5.0% | +4.1% | +9.1% |
| ROCEReturn on capital employed | -7.7% | +9.7% | +6.1% | +4.0% | +8.2% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 6 | 5 | 5 | 6 |
| Debt / EquityFinancial leverage | 12.26x | 0.77x | 1.24x | 0.73x | 0.75x |
| Net DebtTotal debt minus cash | $679M | $54.0B | $85.1B | $8.7B | $23.7B |
| Cash & Equiv.Liquid assets | $11M | $24.4B | $8.5B | $4.2B | $9.5B |
| Total DebtShort + long-term debt | $690M | $78.4B | $93.6B | $12.9B | $33.2B |
| Interest CoverageEBIT ÷ Interest expense | -0.86x | 4.71x | 2.11x | 3.08x | 5.39x |
ELV leads this category, winning 4 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
SNDA leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CVS five years ago would be worth $11,700 today (with dividends reinvested), compared to $5,674 for HUM. Over the past 12 months, SNDA leads with a +52.7% total return vs ELV's -9.0%. The 3-year compound annual growth rate (CAGR) favors SNDA at 73.9% vs HUM's -21.7% — a key indicator of consistent wealth creation.
| Metric | SNDASonida Senior Liv… | UNHUnitedHealth Grou… | CVSCVS Health Corpor… | HUMHumana Inc. | ELVElevance Health I… |
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +14.6% | +10.6% | +10.6% | -6.2% | +5.8% |
| 1-Year ReturnPast 12 months | +52.7% | -3.2% | +34.7% | -1.0% | -9.0% |
| 3-Year ReturnCumulative with dividends | +426.3% | -19.9% | +36.6% | -51.9% | -15.6% |
| 5-Year ReturnCumulative with dividends | -23.8% | -2.6% | +17.0% | -43.3% | +1.5% |
| 10-Year ReturnCumulative with dividends | -87.7% | +220.6% | +3.5% | +59.8% | +202.1% |
| CAGR (3Y)Annualised 3-year return | +73.9% | -7.1% | +11.0% | -21.7% | -5.5% |
SNDA leads this category, winning 4 of 6 comparable metrics.
Risk & Volatility
CVS leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
CVS is the less volatile stock with a 0.05 beta — it tends to amplify market swings less than SNDA's 1.10 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CVS currently trades 98.5% from its 52-week high vs HUM's 78.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | SNDASonida Senior Liv… | UNHUnitedHealth Grou… | CVSCVS Health Corpor… | HUMHumana Inc. | ELVElevance Health I… |
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.10x | 0.59x | 0.05x | 0.56x | 0.46x |
| 52-Week HighHighest price in past year | $38.98 | $395.52 | $88.63 | $315.35 | $424.24 |
| 52-Week LowLowest price in past year | $23.53 | $234.60 | $58.35 | $163.11 | $273.71 |
| % of 52W HighCurrent price vs 52-week peak | +93.8% | +93.5% | +98.5% | +78.4% | +87.9% |
| RSI (14)Momentum oscillator 0–100 | 63.5 | 75.9 | 69.3 | 76.6 | 75.5 |
| Avg Volume (50D)Average daily shares traded | 602K | 7.9M | 7.4M | 1.6M | 1.9M |
CVS leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Evenly matched — UNH and CVS each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: SNDA as "Hold", UNH as "Buy", CVS as "Buy", HUM as "Hold", ELV as "Buy". Consensus price targets imply 9.0% upside for CVS (target: $95) vs -5.2% for SNDA (target: $35). For income investors, CVS offers the higher dividend yield at 3.06% vs SNDA's 0.85%.
| Metric | SNDASonida Senior Liv… | UNHUnitedHealth Grou… | CVSCVS Health Corpor… | HUMHumana Inc. | ELVElevance Health I… |
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $34.67 | $385.43 | $95.20 | $246.00 | $382.38 |
| # AnalystsCovering analysts | 3 | 52 | 41 | 44 | 37 |
| Dividend YieldAnnual dividend ÷ price | +0.9% | +2.4% | +3.1% | +1.4% | +1.8% |
| Dividend StreakConsecutive years of raises | 1 | 25 | 0 | 0 | 15 |
| Dividend / ShareAnnual DPS | $0.31 | $8.70 | $2.67 | $3.56 | $6.89 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.7% | 0.0% | +0.5% | +3.2% |
Evenly matched — UNH and CVS each lead in 1 of 2 comparable metrics.
Key Takeaway
CVS leads in 2 of 6 categories (Valuation Metrics, Risk & Volatility). UNH leads in 1 (Income & Cash Flow). 1 tied.
Best OverallCVS Health Corporation (CVS)Leads 2 of 6 categories
Loading custom metrics...
SNDA vs UNH vs CVS vs HUM vs ELV: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is SNDA or UNH or CVS or HUM or ELV a better buy right now?
For growth investors, Sonida Senior Living, Inc.
(SNDA) is the stronger pick with 25. 2% revenue growth year-over-year, versus 7. 8% for CVS Health Corporation (CVS). Elevance Health Inc. (ELV) offers the better valuation at 14. 8x trailing P/E (13. 9x forward), making it the more compelling value choice. Analysts rate UnitedHealth Group Incorporated (UNH) a "Buy" — based on 52 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SNDA or UNH or CVS or HUM or ELV?
On trailing P/E, Elevance Health Inc.
(ELV) is the cheapest at 14. 8x versus CVS Health Corporation at 62. 8x. On forward P/E, CVS Health Corporation is actually cheaper at 12. 2x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — SNDA or UNH or CVS or HUM or ELV?
Over the past 5 years, CVS Health Corporation (CVS) delivered a total return of +17.
0%, compared to -43. 3% for Humana Inc. (HUM). Over 10 years, the gap is even starker: UNH returned +220. 6% versus SNDA's -87. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SNDA or UNH or CVS or HUM or ELV?
By beta (market sensitivity over 5 years), CVS Health Corporation (CVS) is the lower-risk stock at 0.
05β versus Sonida Senior Living, Inc. 's 1. 10β — meaning SNDA is approximately 2074% more volatile than CVS relative to the S&P 500. On balance sheet safety, Humana Inc. (HUM) carries a lower debt/equity ratio of 73% versus 12% for Sonida Senior Living, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — SNDA or UNH or CVS or HUM or ELV?
By revenue growth (latest reported year), Sonida Senior Living, Inc.
(SNDA) is pulling ahead at 25. 2% versus 7. 8% for CVS Health Corporation (CVS). On earnings-per-share growth, the picture is similar: Humana Inc. grew EPS -1. 4% year-over-year, compared to -681. 5% for Sonida Senior Living, Inc.. Over a 3-year CAGR, SNDA leads at 16. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SNDA or UNH or CVS or HUM or ELV?
Elevance Health Inc.
(ELV) is the more profitable company, earning 2. 8% net margin versus -20. 0% for Sonida Senior Living, Inc. — meaning it keeps 2. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: UNH leads at 4. 2% versus -15. 3% for SNDA. At the gross margin level — before operating expenses — ELV leads at 25. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SNDA or UNH or CVS or HUM or ELV more undervalued right now?
On forward earnings alone, CVS Health Corporation (CVS) trades at 12.
2x forward P/E versus 27. 7x for Humana Inc. — 15. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CVS: 9. 0% to $95. 20.
08Which pays a better dividend — SNDA or UNH or CVS or HUM or ELV?
All stocks in this comparison pay dividends.
CVS Health Corporation (CVS) offers the highest yield at 3. 1%, versus 0. 9% for Sonida Senior Living, Inc. (SNDA).
09Is SNDA or UNH or CVS or HUM or ELV better for a retirement portfolio?
For long-horizon retirement investors, CVS Health Corporation (CVS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
05), 3. 1% yield). Both have compounded well over 10 years (CVS: +3. 5%, SNDA: -87. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SNDA and UNH and CVS and HUM and ELV?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: SNDA is a small-cap high-growth stock; UNH is a large-cap quality compounder stock; CVS is a mid-cap income-oriented stock; HUM is a mid-cap quality compounder stock; ELV is a mid-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
Revenue Growth>
%
(SNDA: 6.2% · UNH: 2.0%)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.